Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

2.16
Delayed Data
As of 3:59pm ET
 +0.07 / +3.35%
Today’s Change
2.00
Today|||52-Week Range
9.35
-3.57%
Year-to-Date

Today’s Trading

Previous close2.09
Today’s open2.09
Day’s range2.06 - 2.22
Volume1,041,288
Average volume (3 months)351,820
Market cap$32.5M
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-156.17%
Earnings growth (this year)+13.99%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.39

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...+0.07+0.35%
RTTRRitter Pharmaceutica...-0.14-4.71%
OGENOragenics Inc-0.03-3.97%
AXNAoxing Pharmaceutica...+0.03+6.66%
Data as of 4:02pm ET, 01/23/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Financial Officer &
Secretary
R. Michael Carruthers
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs